Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 51.50
-1.00 (-1.90%)
Feb 21, 2025, 4:35 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 19.44 million as of February 21, 2025. Its market cap has decreased by -59.43% in one year.
Market Cap
19.44M
Enterprise Value
17.18M
Revenue
4.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 19.44M, a decrease of -70.98%. That is a compound annual growth rate of -28.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 19.44M | -29.93% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.48B |
| GSK plc | 58.67B |
| Haleon | 35.36B |
| Smith & Nephew | 8.91B |
| Hikma Pharmaceuticals | 5.09B |
| ConvaTec Group | 5.01B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.24B |